Thursday, September 18, 2025
HomeNews

News

Artera Announces Positive Results Around Its Multimodal Artificial Intelligence (MMAI) Prognostic Biomarker

Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced new data at ASCO GU 2023 demonstrating that its multimodal artificial intelligence...

Diagnostix Expands into Motorsports with Revolutionary Biometric Measurement Device for Performance Analytics

Diagnostix, a medtech company specializing in AI-powered radiology imaging for hospitals, is now expanding its reach into the world of motorsports and Formula One...

Code Ocean Partners with Nature Portfolio to Launch the Open Science Library with Ready-to-Run Software from Authors in Nature Journals

Code Ocean, the world's first Reproducible Research Cloud, announced that it has partnered with Nature Portfolio to launch a curated Open Science Library, containing research...

Trodelvy Demonstrates Positive Efficacy Treating Both Platinum-Ineligible and Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer

Gilead Sciences, Inc. announced new and updated positive results from three cohorts of the Phase 2 TROPHY-U-01 study of Trodelvy for the treatment of...

Adjuvant Opdivo (nivolumab) Continues to Provide Significant, Durable Clinical Benefits for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma After Three Years in CheckMate...

Bristol Myers Squibb announced three-year follow-up results from the Phase 3 CheckMate -274 trial, demonstrating significant sustained clinical benefits with Opdivo (nivolumab) for the adjuvant...
0FansLike
0FollowersFollow
spot_img

Hot Topics